June 11, 2014—The 340B program should be reconfigured to directly benefit uninsured and otherwise needy patients instead of benefitting hospitals, several speakers said yesterday during a drug industry sponsored meeting on the drug discount program. Participants representing non-hospital 340B covered entities, however, cautioned against recasting 340B as a type of patient drug assistance program.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)